Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Journey Medical Corporation (DERM)
Last journey medical corporation earnings: 11/5 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.dermira.com
Company Research
Source: Yahoo! Finance
Emrosi Revenue: $4.9 million in Q3, a 75% increase compared to Q2. Gross Margin: 67.4% in Q3, compared to 69.4% in Q3 2024. SG&A Expenses: $12.1 million, up 6% from $11.4 million in Q3 2024. Net Loss: $2.3 million or $0.09 per share, compared to $2.4 million or $0.12 per share in Q3 2024. EBITDA: Improved by $500,000 from a loss of $1 million in Q3 2024 to a loss of $500,000 in Q3 2025. Adjusted EBITDA: Positive $1.7 million, compared to $300,000 in Q3 2024. Cash and Cash Equivalents: $24.9 million at the end of Q3, up from $20.3 million at December 31, 2024. Emrosi Prescriptions: 18,198 in Q3, a 146% increase from 7,394 in Q2. Unique Emrosi Prescribers: Over 2,700, a 50% increase from the previous report. Warning! GuruFocus has detected 4 Warning Signs with DERM. Is DERM fairly valued? Test your thesis with our free DCF calculator. Release Date: November 12, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcri
Show less
Read more
Impact Snapshot
Event Time:
DERM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DERM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DERM alerts
High impacting Journey Medical Corporation news events
Weekly update
A roundup of the hottest topics
DERM
News
- What Makes Journey Medical Corporation (DERM) a Good Investment? [Yahoo! Finance]Yahoo! Finance
- Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Journey Medical Corporation (DERM) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]Yahoo! Finance
- Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate HighlightsGlobeNewswire
DERM
Earnings
- 11/12/25 - Beat
DERM
Sec Filings
- 11/12/25 - Form 10-Q
- 11/12/25 - Form 8-K
- 9/26/25 - Form 8-K
- DERM's page on the SEC website